WASHINGTON – Federal health regulators are warning the public that certain cardiac defibrillators recalled by Philips Healthcare may fail to deliver a needed shock in an emergency. Defibrillators are ...

Sept. 23, 2004 -- The U.S. Food and Drug Administration (FDA) has approved a home defibrillator for sale without a prescription; a C-reactive protein assay to determine the risk of coronary heart ...

Please provide your email address to receive an email when new articles are posted on . The FDA has issued a safety communication indicating that certain HeartStart automated external defibrillators ...

The Food and Drug Administration (FDA) is warning consumers that some models of HeartStart automated external defibrillators (AED) may not work during a cardiac emergency. The devices, which are made ...

The US Food and Drug Administration (FDA) is classifying a recent safety notice covering certain models of the HeartStart MRx Monitor/Defibrillator due to electrical and battery connection issues as a ...

Feb. 14, 2003 - The U.S. Food and Drug Administration (FDA) has approved Phillips Electronics' automatic external defibrillator (AED) for marketing. The HeartStart Home Defibrillator is designed for ...

Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...

Philips recalled its HeartStart MRx Defibrillator due to an equipment defect, according to a Feb. 9 safety notice from the FDA. Here are three things to know. 1. Philips initiated the recall in June ...

The Philips HeartStart FRx Defibrillator is designed to be easy to set up and use, as well as rugged and reliable for those who get there first. On the scene with law enforcement, on the field with ...

Hundreds of thousands of automated external defibrillators (AEDs) made by Philips Healthcare might not deliver a needed shock to the heart in an emergency, the U.S. Food and Drug Administration said ...

Amsterdam, the Netherlands and Cambridge, MA– Royal Philips  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) ...

Royal Philips, a global leader in health technology, announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has approved the company’s premarket ...